ID: ALA2401862

Max Phase: Preclinical

Molecular Formula: C25H22F3N3O2S

Molecular Weight: 485.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)c1ccccc1Oc1ncccc1Nc1nc(C(F)(F)F)c(-c2ccccc2O)s1

Standard InChI:  InChI=1S/C25H22F3N3O2S/c1-24(2,3)16-10-5-7-13-19(16)33-22-17(11-8-14-29-22)30-23-31-21(25(26,27)28)20(34-23)15-9-4-6-12-18(15)32/h4-14,32H,1-3H3,(H,30,31)

Standard InChI Key:  VCIBBTYXCNQYLH-UHFFFAOYSA-N

Associated Targets(Human)

Purinergic receptor P2Y1 1327 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 485.53Molecular Weight (Monoisotopic): 485.1385AlogP: 7.76#Rotatable Bonds: 5
Polar Surface Area: 67.27Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.00CX Basic pKa: 2.22CX LogP: 7.78CX LogD: 7.77
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.30Np Likeness Score: -1.15

References

1. Pi Z, Sutton J, Lloyd J, Hua J, Price L, Wu Q, Chang M, Zheng J, Rehfuss R, Huang CS, Wexler RR, Lam PY..  (2013)  2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.,  23  (14): [PMID:23743287] [10.1016/j.bmcl.2013.05.025]
2. Hossain N, Ivanova S, Timén ÅS, Bergare J, Mussie T, Bergström L..  (2013)  Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists.,  23  (14): [PMID:23769642] [10.1016/j.bmcl.2013.05.087]

Source